Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2017

Feb 14, 2018

SELL
$15.77 - $20.72 $11.8 Million - $15.5 Million
-750,423 Closed
0 $0
Q3 2017

Nov 14, 2017

BUY
$12.3 - $19.3 $9.23 Million - $14.5 Million
750,423
750,423 $14.5 Million

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $5.51B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Investor Ab Portfolio

Follow Investor Ab and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investor Ab, based on Form 13F filings with the SEC.

News

Stay updated on Investor Ab with notifications on news.